Filings

7 documents · 28 matches

1. MNPR Monopar Therapeutics 10-K 2026-03-27

   Item 1A. Risk Factors

   tariffs have led to increased trade and political tensions. In response to tariffs, other countries have implemented retaliatory tariffs on U.S. goods
   8 matches in this document Show context Copy citation

2. MNPR Monopar Therapeutics 10-Q 2026-08-12

   Item 6.

   tariffs, and regulations or executive orders, and may, in turn, lead to increased or decreased governmental control of healthcare and pharmaceuticals
   3 matches in this document Show context Copy citation

3. MNPR Monopar Therapeutics 10-Q 2026-05-14

   Item 6.

   tariffs, and regulations or executive orders, and may, in turn, lead to increased or decreased governmental control of healthcare and pharmaceuticals
   3 matches in this document Show context Copy citation

4. MNPR Monopar Therapeutics 10-Q 2025-11-13

   Item 6.

   tariffs, and regulations or executive orders, and may, in turn, lead to increased or decreased governmental control of healthcare and pharmaceuticals
   3 matches in this document Show context Copy citation

5. MNPR Monopar Therapeutics 10-Q 2025-08-12

   Item 6.

   tariffs, and regulations or executive orders, and may in turn lead to increased or decreased governmental control of healthcare and pharmaceuticals
   3 matches in this document Show context Copy citation

6. MNPR Monopar Therapeutics 10-Q 2025-05-13

   Item 6.

   tariffs, and regulations or executive orders, and may in turn lead to increased or decreased governmental control of healthcare and pharmaceuticals
   3 matches in this document Show context Copy citation

7. MNPR Monopar Therapeutics 10-Q 2026-11-12

   Item 6.

   tariffs, regulations and/or executive orders may, in turn, lead to increased or decreased governmental control of healthcare and pharmaceuticals, with
   5 matches in this document Show context Copy citation